Parker Waichman LLP has filed a lawsuit alleging that Actos (pioglitazone) caused bladder cancer in a New Jersey man. The Type 2 diabetes medication is associated with an increased risk of bladder cancer, most recently in a study published in the Journal of the National Cancer Institute.
(PRWeb October 11, 2012)
Read the full story at http://www.prweb.com/releases/actosbladdercancer/102012/prweb10006420.htm
